bullish
Akeso Placement - Opportunistic Raise, past Deal Record Has Been Mixed but Relative Size Is Small
441 Views10 Oct 2024 19:38
Akeso Biopharma Inc (9926 HK) is looking to raise around US$200m from its primary placement. Proceeds from the placement will be used for R&D.
What is covered in the Full Insight:
- Introduction
- Deal Terms and Dynamics
- Recent Performance and Financials
- Pipeline and Analyst Expectations
- Conclusion and Recommendations
SUMMARY
(Sign Up to Access)Begin exploring Smartkarma's AI-augmented investing intelligence platform with a complimentary Preview Pass to:
- Unlock research summaries
- Follow top, independent analysts
- Receive personalised alerts
- Access Analytics, Events and more
Join 55,000+ investors, including top global asset managers overseeing $13+ trillion.
Upgrade later to our paid plans for full-access.
or
Already have an account? Sign In Now
Full Insight
(Paid Plans Only, 4-minute read)
Discussions
(Paid Plans Only)
x